Chinese biotech firm Genecast secures $149m in Series E round

Chinese biotech firm Genecast secures $149m in Series E round

Laboratory equipment. Photo: Pixabay

Genecast Biotechnology, a Chinese biotech firm that specialises in next-generation sequencing (NGS) technology and bioinformatics, has secured over 1 billion yuan ($149 million) in a Series E round of financing, the firm announced on Monday.